nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—chronic kidney failure	0.924	1	CbGaD
Salbutamol—Clenbuterol—NGF—chronic kidney failure	0.00689	0.473	CrCbGaD
Salbutamol—Norepinephrine—SLC22A2—chronic kidney failure	0.00143	0.0982	CrCbGaD
Salbutamol—Clenbuterol—TNF—chronic kidney failure	0.00134	0.0917	CrCbGaD
Salbutamol—Epinephrine—SLC22A2—chronic kidney failure	0.0013	0.0891	CrCbGaD
Salbutamol—Clenbuterol—CYP1A1—chronic kidney failure	0.00101	0.0697	CrCbGaD
Salbutamol—Salmeterol—CYP3A4—chronic kidney failure	0.000689	0.0473	CrCbGaD
Salbutamol—Epinephrine—TNF—chronic kidney failure	0.000561	0.0385	CrCbGaD
Salbutamol—Nadolol—ABCB1—chronic kidney failure	0.000559	0.0384	CrCbGaD
Salbutamol—Isoprenaline—CYP1A1—chronic kidney failure	0.000507	0.0349	CrCbGaD
Salbutamol—Epinephrine—CYP3A4—chronic kidney failure	0.000272	0.0187	CrCbGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—chronic kidney failure	0.000222	0.00361	CbGpPWpGaD
Salbutamol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000221	0.0036	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPY—chronic kidney failure	0.000217	0.00353	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPY—chronic kidney failure	0.000212	0.00345	CbGpPWpGaD
Salbutamol—CYP3A4—Tryptophan metabolism—CAT—chronic kidney failure	0.000212	0.00345	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000211	0.00344	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OXT—chronic kidney failure	0.000209	0.0034	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CRHR1—chronic kidney failure	0.000208	0.00338	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OXT—chronic kidney failure	0.000205	0.00333	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CRHR1—chronic kidney failure	0.000203	0.00331	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—POMC—chronic kidney failure	0.0002	0.00325	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	0.000198	0.00323	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—POMC—chronic kidney failure	0.000196	0.00318	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	0.000195	0.00317	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—chronic kidney failure	0.000194	0.00316	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.000193	0.00314	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—chronic kidney failure	0.00019	0.0031	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—PTH—chronic kidney failure	0.00019	0.00309	CbGpPWpGaD
Salbutamol—CYP3A4—Tryptophan metabolism—CYP1A1—chronic kidney failure	0.00019	0.00309	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—PTH—chronic kidney failure	0.000186	0.00303	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—NPY—chronic kidney failure	0.000165	0.00269	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—NPY—chronic kidney failure	0.000162	0.00263	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CRH—chronic kidney failure	0.000159	0.00259	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—OXT—chronic kidney failure	0.000159	0.00259	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP2B6—chronic kidney failure	0.000156	0.00254	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—OXT—chronic kidney failure	0.000156	0.00254	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CRH—chronic kidney failure	0.000156	0.00254	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000154	0.00251	CbGpPWpGaD
Salbutamol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.000154	0.0025	CbGpPWpGaD
Salbutamol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.000151	0.00246	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—NPS—chronic kidney failure	0.000151	0.00246	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD1—chronic kidney failure	0.000148	0.00241	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—NPS—chronic kidney failure	0.000148	0.0024	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD1—chronic kidney failure	0.000145	0.00236	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.000143	0.00233	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.000142	0.00232	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.00014	0.00228	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.000139	0.00227	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.000136	0.00222	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.000135	0.0022	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP2C18—chronic kidney failure	0.000135	0.0022	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000134	0.00217	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.000133	0.00217	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.000132	0.00215	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000124	0.00202	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.000122	0.00198	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.000119	0.00194	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CRHR1—chronic kidney failure	0.000118	0.00191	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CRHR1—chronic kidney failure	0.000115	0.00187	CbGpPWpGaD
Salbutamol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.000114	0.00186	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	0.000112	0.00182	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000111	0.0018	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—AVP—chronic kidney failure	0.000109	0.00178	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PTH—chronic kidney failure	0.000107	0.00175	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—AVP—chronic kidney failure	0.000107	0.00174	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CRHR1—chronic kidney failure	0.000107	0.00174	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PTH—chronic kidney failure	0.000105	0.00171	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.000105	0.0017	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CRHR1—chronic kidney failure	0.000104	0.0017	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—EDN1—chronic kidney failure	0.000104	0.00169	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCL5—chronic kidney failure	0.000103	0.00168	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	0.000103	0.00167	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.000102	0.00167	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—EDN1—chronic kidney failure	0.000102	0.00165	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCL5—chronic kidney failure	0.000101	0.00164	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PTH—chronic kidney failure	9.76e-05	0.00159	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PTH—chronic kidney failure	9.55e-05	0.00155	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	9.53e-05	0.00155	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPY—chronic kidney failure	9.34e-05	0.00152	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	9.33e-05	0.00152	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	9.32e-05	0.00152	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCR5—chronic kidney failure	9.29e-05	0.00151	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	9.28e-05	0.00151	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPY—chronic kidney failure	9.13e-05	0.00149	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	9.12e-05	0.00148	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCR5—chronic kidney failure	9.09e-05	0.00148	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OXT—chronic kidney failure	9.01e-05	0.00147	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CRH—chronic kidney failure	9.01e-05	0.00147	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—COL4A5—chronic kidney failure	8.95e-05	0.00146	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OXT—chronic kidney failure	8.81e-05	0.00143	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CRH—chronic kidney failure	8.81e-05	0.00143	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—COL4A5—chronic kidney failure	8.75e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPS—chronic kidney failure	8.54e-05	0.00139	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPY—chronic kidney failure	8.48e-05	0.00138	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD1—chronic kidney failure	8.37e-05	0.00136	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPS—chronic kidney failure	8.35e-05	0.00136	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TFDP2—chronic kidney failure	8.32e-05	0.00135	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPY—chronic kidney failure	8.29e-05	0.00135	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD1—chronic kidney failure	8.19e-05	0.00133	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CRH—chronic kidney failure	8.18e-05	0.00133	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OXT—chronic kidney failure	8.18e-05	0.00133	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIP5K1B—chronic kidney failure	8.14e-05	0.00132	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TFDP2—chronic kidney failure	8.14e-05	0.00132	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OXT—chronic kidney failure	8e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CRH—chronic kidney failure	8e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—F2—chronic kidney failure	7.97e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIP5K1B—chronic kidney failure	7.96e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—F2—chronic kidney failure	7.79e-05	0.00127	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPS—chronic kidney failure	7.75e-05	0.00126	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD1—chronic kidney failure	7.6e-05	0.00124	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPS—chronic kidney failure	7.58e-05	0.00123	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD1—chronic kidney failure	7.44e-05	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PGF—chronic kidney failure	7.41e-05	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—POMC—chronic kidney failure	7.26e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PGF—chronic kidney failure	7.25e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCL2—chronic kidney failure	7.1e-05	0.00116	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—POMC—chronic kidney failure	7.1e-05	0.00116	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKAG2—chronic kidney failure	6.97e-05	0.00113	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCL2—chronic kidney failure	6.95e-05	0.00113	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKAG2—chronic kidney failure	6.82e-05	0.00111	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	6.61e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—COL4A3—chronic kidney failure	6.61e-05	0.00108	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	6.52e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HBEGF—chronic kidney failure	6.47e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—COL4A3—chronic kidney failure	6.46e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HBEGF—chronic kidney failure	6.32e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CRHR1—chronic kidney failure	6.3e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AVP—chronic kidney failure	6.17e-05	0.001	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CRHR1—chronic kidney failure	6.17e-05	0.001	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LRP2—chronic kidney failure	6.04e-05	0.000983	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AVP—chronic kidney failure	6.04e-05	0.000982	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LRP2—chronic kidney failure	5.91e-05	0.000962	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—EDN1—chronic kidney failure	5.87e-05	0.000955	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCL5—chronic kidney failure	5.83e-05	0.000948	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTH—chronic kidney failure	5.77e-05	0.000938	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—EDN1—chronic kidney failure	5.74e-05	0.000934	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCL5—chronic kidney failure	5.7e-05	0.000927	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTH—chronic kidney failure	5.64e-05	0.000918	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CYBB—chronic kidney failure	5.62e-05	0.000914	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AVP—chronic kidney failure	5.61e-05	0.000912	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CYBB—chronic kidney failure	5.5e-05	0.000894	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AVP—chronic kidney failure	5.48e-05	0.000892	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—EDN1—chronic kidney failure	5.33e-05	0.000867	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGF23—chronic kidney failure	5.32e-05	0.000866	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL5—chronic kidney failure	5.29e-05	0.000861	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCR5—chronic kidney failure	5.25e-05	0.000854	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—EDN1—chronic kidney failure	5.22e-05	0.000849	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGF23—chronic kidney failure	5.2e-05	0.000847	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL5—chronic kidney failure	5.18e-05	0.000842	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCR5—chronic kidney failure	5.13e-05	0.000835	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPY—chronic kidney failure	5.01e-05	0.000815	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—POMC—chronic kidney failure	4.93e-05	0.000802	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPY—chronic kidney failure	4.9e-05	0.000797	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CRH—chronic kidney failure	4.83e-05	0.000786	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OXT—chronic kidney failure	4.83e-05	0.000786	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCR5—chronic kidney failure	4.77e-05	0.000775	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OXT—chronic kidney failure	4.73e-05	0.000769	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CRH—chronic kidney failure	4.73e-05	0.000769	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCR5—chronic kidney failure	4.66e-05	0.000759	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FABP1—chronic kidney failure	4.65e-05	0.000756	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NCF1—chronic kidney failure	4.63e-05	0.000753	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPS—chronic kidney failure	4.58e-05	0.000745	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NCF1—chronic kidney failure	4.53e-05	0.000736	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—F2—chronic kidney failure	4.5e-05	0.000733	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD1—chronic kidney failure	4.49e-05	0.000731	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPS—chronic kidney failure	4.48e-05	0.000729	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AGXT—chronic kidney failure	4.41e-05	0.000717	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GATM—chronic kidney failure	4.41e-05	0.000717	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—F2—chronic kidney failure	4.4e-05	0.000717	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD1—chronic kidney failure	4.39e-05	0.000715	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CYBA—chronic kidney failure	4.35e-05	0.000708	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CYBA—chronic kidney failure	4.26e-05	0.000692	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—POMC—chronic kidney failure	4.1e-05	0.000667	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—F2—chronic kidney failure	4.09e-05	0.000665	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACAT1—chronic kidney failure	4.03e-05	0.000656	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—chronic kidney failure	4.01e-05	0.000653	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—F2—chronic kidney failure	4e-05	0.000651	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HBEGF—chronic kidney failure	3.82e-05	0.000621	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	3.75e-05	0.00061	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HBEGF—chronic kidney failure	3.74e-05	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—chronic kidney failure	3.73e-05	0.000606	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL2—chronic kidney failure	3.64e-05	0.000593	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—chronic kidney failure	3.64e-05	0.000593	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—chronic kidney failure	3.57e-05	0.00058	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	3.43e-05	0.000558	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AVP—chronic kidney failure	3.31e-05	0.000539	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AVP—chronic kidney failure	3.24e-05	0.000527	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCG1—chronic kidney failure	3.19e-05	0.000518	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EDN1—chronic kidney failure	3.15e-05	0.000512	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL5—chronic kidney failure	3.13e-05	0.000508	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	3.12e-05	0.000507	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EDN1—chronic kidney failure	3.08e-05	0.000501	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL5—chronic kidney failure	3.06e-05	0.000497	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LPL—chronic kidney failure	3.06e-05	0.000497	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ARG2—chronic kidney failure	3.05e-05	0.000497	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LCAT—chronic kidney failure	3e-05	0.000487	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LPL—chronic kidney failure	2.99e-05	0.000486	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NGF—chronic kidney failure	2.89e-05	0.000471	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NGF—chronic kidney failure	2.83e-05	0.000461	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCR5—chronic kidney failure	2.82e-05	0.000458	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCR5—chronic kidney failure	2.75e-05	0.000448	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DDC—chronic kidney failure	2.75e-05	0.000447	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	2.67e-05	0.000434	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	2.67e-05	0.000434	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRKD1—chronic kidney failure	2.67e-05	0.000434	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SREBF2—chronic kidney failure	2.5e-05	0.000407	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—F2—chronic kidney failure	2.42e-05	0.000393	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCKR—chronic kidney failure	2.41e-05	0.000393	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCC3—chronic kidney failure	2.41e-05	0.000393	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—F2—chronic kidney failure	2.36e-05	0.000384	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPIN1—chronic kidney failure	2.36e-05	0.000384	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LRP2—chronic kidney failure	2.31e-05	0.000377	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	2.31e-05	0.000377	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IRS1—chronic kidney failure	2.29e-05	0.000372	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IRS1—chronic kidney failure	2.24e-05	0.000364	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—chronic kidney failure	2.2e-05	0.000358	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—chronic kidney failure	2.15e-05	0.00035	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—chronic kidney failure	2.15e-05	0.00035	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—chronic kidney failure	2.12e-05	0.000344	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—chronic kidney failure	2.11e-05	0.000343	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—chronic kidney failure	2.07e-05	0.000337	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—chronic kidney failure	2.01e-05	0.000327	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—KRAS—chronic kidney failure	1.99e-05	0.000324	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.97e-05	0.00032	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—chronic kidney failure	1.97e-05	0.00032	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—KRAS—chronic kidney failure	1.95e-05	0.000317	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—chronic kidney failure	1.92e-05	0.000312	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.92e-05	0.000312	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.92e-05	0.000312	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—chronic kidney failure	1.88e-05	0.000305	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RELA—chronic kidney failure	1.81e-05	0.000294	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.77e-05	0.000288	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RELA—chronic kidney failure	1.77e-05	0.000287	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.75e-05	0.000285	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.72e-05	0.00028	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.67e-05	0.000272	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FASN—chronic kidney failure	1.64e-05	0.000266	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—chronic kidney failure	1.62e-05	0.000263	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—chronic kidney failure	1.58e-05	0.000258	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NFKB1—chronic kidney failure	1.52e-05	0.000248	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.49e-05	0.000243	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NFKB1—chronic kidney failure	1.49e-05	0.000242	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VEGFA—chronic kidney failure	1.38e-05	0.000225	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VEGFA—chronic kidney failure	1.35e-05	0.00022	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—chronic kidney failure	1.27e-05	0.000206	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAT—chronic kidney failure	1.26e-05	0.000205	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—chronic kidney failure	1.24e-05	0.000202	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.23e-05	0.0002	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KRAS—chronic kidney failure	1.18e-05	0.000191	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPL—chronic kidney failure	1.17e-05	0.00019	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KRAS—chronic kidney failure	1.15e-05	0.000187	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	1.13e-05	0.000184	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—chronic kidney failure	1.05e-05	0.000171	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARA—chronic kidney failure	1.03e-05	0.000168	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—chronic kidney failure	9.56e-06	0.000156	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—chronic kidney failure	9.35e-06	0.000152	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—chronic kidney failure	8.43e-06	0.000137	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—chronic kidney failure	7.68e-06	0.000125	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—chronic kidney failure	7.35e-06	0.00012	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—chronic kidney failure	6.72e-06	0.000109	CbGpPWpGaD
